↓ Skip to main content

Targeting the Toll-like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
33 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting the Toll-like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors
Published in
Clinical Lymphoma, Myeloma & Leukemia, March 2013
DOI 10.1016/j.clml.2013.02.003
Pubmed ID
Authors

Maria Loiarro, Vito Ruggiero, Claudio Sette

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 24%
Other 6 18%
Researcher 4 12%
Student > Bachelor 3 9%
Professor 3 9%
Other 6 18%
Unknown 3 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 24%
Medicine and Dentistry 8 24%
Chemistry 5 15%
Biochemistry, Genetics and Molecular Biology 4 12%
Immunology and Microbiology 2 6%
Other 2 6%
Unknown 4 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2022.
All research outputs
#3,798,611
of 25,373,627 outputs
Outputs from Clinical Lymphoma, Myeloma & Leukemia
#214
of 2,059 outputs
Outputs of similar age
#31,025
of 208,876 outputs
Outputs of similar age from Clinical Lymphoma, Myeloma & Leukemia
#1
of 14 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,059 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,876 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.